-
1
-
-
0031014450
-
Cancer statistics
-
10.3322/canjclin.47.1.5, 8996076
-
Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1997, 47:5-27. 10.3322/canjclin.47.1.5, 8996076.
-
(1997)
CA Cancer J Clin
, vol.47
, pp. 5-27
-
-
Parker, S.L.1
Tong, T.2
Bolden, S.3
Wingo, P.A.4
-
2
-
-
0031723678
-
Management of the patient with progressive radioiodine non-responsive disease
-
10.1002/(SICI)1098-2388(199901/02)16:1<34::AID-SSU7>3.0.CO;2-2, 9890738
-
Haugen BR. Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol 1999, 16:34-41. 10.1002/(SICI)1098-2388(199901/02)16:1<34::AID-SSU7>3.0.CO;2-2, 9890738.
-
(1999)
Semin Surg Oncol
, vol.16
, pp. 34-41
-
-
Haugen, B.R.1
-
3
-
-
42549088683
-
Thyroid carcinoma: molecular pathways and therapeutic targets
-
10.1038/modpathol.2008.10, 2673022, 18437172
-
Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 2008, 21(Suppl 2):S37-S43. 10.1038/modpathol.2008.10, 2673022, 18437172.
-
(2008)
Mod Pathol
, vol.21
, Issue.SUPPL 2
-
-
Nikiforov, Y.E.1
-
4
-
-
50649101341
-
Refractory thyroid cancer: a paradigm shift in treatment is not far off
-
10.1200/JCO.2008.17.3682, 18541893
-
Pfister DG, Fagin JA. Refractory thyroid cancer: a paradigm shift in treatment is not far off. J Clin Oncol 2008, 26:4701-4704. 10.1200/JCO.2008.17.3682, 18541893.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4701-4704
-
-
Pfister, D.G.1
Fagin, J.A.2
-
5
-
-
75549086941
-
Molecularly targeted therapies for thyroid cancers
-
10.4158/EP09131.RAR, 19546052
-
Sherman SI. Molecularly targeted therapies for thyroid cancers. Endocr Pract 2009, 15:605-611. 10.4158/EP09131.RAR, 19546052.
-
(2009)
Endocr Pract
, vol.15
, pp. 605-611
-
-
Sherman, S.I.1
-
6
-
-
33749078761
-
NF-kappaB in solid tumors
-
10.1016/j.bcp.2006.07.032, 16956585
-
Pacifico F, Leonardi A. NF-kappaB in solid tumors. Biochem Pharmacol 2006, 72:1142-1152. 10.1016/j.bcp.2006.07.032, 16956585.
-
(2006)
Biochem Pharmacol
, vol.72
, pp. 1142-1152
-
-
Pacifico, F.1
Leonardi, A.2
-
7
-
-
26444584958
-
Nuclear factor-kappaB and liver carcinogenesis
-
10.1016/j.canlet.2005.07.008, 16125305
-
Arsura M, Cavin LG. Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett 2005, 229:157-169. 10.1016/j.canlet.2005.07.008, 16125305.
-
(2005)
Cancer Lett
, vol.229
, pp. 157-169
-
-
Arsura, M.1
Cavin, L.G.2
-
8
-
-
33947527353
-
Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells
-
10.1038/sj.onc.1209994, 1903341, 17001349
-
Liu J, Suresh Kumar KG, Yu D, Molton SA, McMahon M, Herlyn M, Thomas-Tikhonenko A, Fuchs SY. Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Oncogene 2007, 26:1954-1958. 10.1038/sj.onc.1209994, 1903341, 17001349.
-
(2007)
Oncogene
, vol.26
, pp. 1954-1958
-
-
Liu, J.1
Suresh Kumar, K.G.2
Yu, D.3
Molton, S.A.4
McMahon, M.5
Herlyn, M.6
Thomas-Tikhonenko, A.7
Fuchs, S.Y.8
-
9
-
-
33846570444
-
The transcription factor nuclear factor-kappa B and cancer
-
Escarcega RO, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A, Zamora A. The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol) 2007, 19:154-161.
-
(2007)
Clin Oncol (R Coll Radiol)
, vol.19
, pp. 154-161
-
-
Escarcega, R.O.1
Fuentes-Alexandro, S.2
Garcia-Carrasco, M.3
Gatica, A.4
Zamora, A.5
-
10
-
-
58149109907
-
Signaling loops and linear pathways: NF-kappaB activation in response to genotoxic stress
-
10.1093/mutage/gen056, 18832076
-
Brzoska K, Szumiel I. Signaling loops and linear pathways: NF-kappaB activation in response to genotoxic stress. Mutagenesis 2009, 24:1-8. 10.1093/mutage/gen056, 18832076.
-
(2009)
Mutagenesis
, vol.24
, pp. 1-8
-
-
Brzoska, K.1
Szumiel, I.2
-
11
-
-
43749098070
-
NF-kappaB and cancer-identifying targets and mechanisms
-
10.1016/j.gde.2008.01.020, 2587362, 18440219
-
Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008, 18:19-26. 10.1016/j.gde.2008.01.020, 2587362, 18440219.
-
(2008)
Curr Opin Genet Dev
, vol.18
, pp. 19-26
-
-
Naugler, W.E.1
Karin, M.2
-
12
-
-
33745298519
-
Nuclear factor-kappaB in cancer development and progression
-
10.1038/nature04870, 16724054
-
Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436. 10.1038/nature04870, 16724054.
-
(2006)
Nature
, vol.441
, pp. 431-436
-
-
Karin, M.1
-
13
-
-
6044271614
-
Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin
-
10.1158/1078-0432.CCR-04-0463, 15501958
-
Starenki DV, Namba H, Saenko VA, Ohtsuru A, Maeda S, Umezawa W, Yamashita S. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin. Clin Cancer Res 2004, 10:6821-6829. 10.1158/1078-0432.CCR-04-0463, 15501958.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6821-6829
-
-
Starenki, D.V.1
Namba, H.2
Saenko, V.A.3
Ohtsuru, A.4
Maeda, S.5
Umezawa, W.6
Yamashita, S.7
-
14
-
-
54349105133
-
Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cells
-
10.1210/en.2008-0279, 18653704
-
Meng Z, Mitsutake N, Nakashima M, Starenki D, Matsuse M, Takakura S, Namba H, Saenko V, Umezawa K, Ohtsuru A, Yamashita S. Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cells. Endocrinology 2008, 149:5357-5365. 10.1210/en.2008-0279, 18653704.
-
(2008)
Endocrinology
, vol.149
, pp. 5357-5365
-
-
Meng, Z.1
Mitsutake, N.2
Nakashima, M.3
Starenki, D.4
Matsuse, M.5
Takakura, S.6
Namba, H.7
Saenko, V.8
Umezawa, K.9
Ohtsuru, A.10
Yamashita, S.11
-
15
-
-
63849258626
-
A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway
-
10.1124/mol.108.052605, 19158360
-
Zhu W, Ou Y, Li Y, Xiao R, Shu M, Zhou Y, Xie J, He S, Qiu P, Yan G. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol 2009, 75:812-819. 10.1124/mol.108.052605, 19158360.
-
(2009)
Mol Pharmacol
, vol.75
, pp. 812-819
-
-
Zhu, W.1
Ou, Y.2
Li, Y.3
Xiao, R.4
Shu, M.5
Zhou, Y.6
Xie, J.7
He, S.8
Qiu, P.9
Yan, G.10
-
16
-
-
33748744702
-
Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro
-
10.1210/jc.2005-2472, 16849420
-
Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, Fanourakis G, Tseleni-Balafouta S, Ain KB, Mitsiades N. Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. J Clin Endocrinol Metab 2006, 91:4013-4021. 10.1210/jc.2005-2472, 16849420.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 4013-4021
-
-
Mitsiades, C.S.1
McMillin, D.2
Kotoula, V.3
Poulaki, V.4
McMullan, C.5
Negri, J.6
Fanourakis, G.7
Tseleni-Balafouta, S.8
Ain, K.B.9
Mitsiades, N.10
-
17
-
-
50649099936
-
Potent inhibition of thyroid cancer cells by the MEK inhibitor PD0325901 and its potentiation by suppression of the PI3K and NF-kappaB pathways
-
10.1089/thy.2007.0357, 2857450, 18651802
-
Liu D, Xing M. Potent inhibition of thyroid cancer cells by the MEK inhibitor PD0325901 and its potentiation by suppression of the PI3K and NF-kappaB pathways. Thyroid 2008, 18:853-864. 10.1089/thy.2007.0357, 2857450, 18651802.
-
(2008)
Thyroid
, vol.18
, pp. 853-864
-
-
Liu, D.1
Xing, M.2
-
18
-
-
57349103343
-
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification
-
10.1210/jc.2008-1102, 2582569, 18713817
-
Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 2008, 93:4331-4341. 10.1210/jc.2008-1102, 2582569, 18713817.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 4331-4341
-
-
Schweppe, R.E.1
Klopper, J.P.2
Korch, C.3
Pugazhenthi, U.4
Benezra, M.5
Knauf, J.A.6
Fagin, J.A.7
Marlow, L.A.8
Copland, J.A.9
Smallridge, R.C.10
Haugen, B.R.11
-
19
-
-
0346505340
-
The IKK NF-kappa B system: a treasure trove for drug development
-
10.1038/nrd1279, 14708018
-
Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 2004, 3:17-26. 10.1038/nrd1279, 14708018.
-
(2004)
Nat Rev Drug Discov
, vol.3
, pp. 17-26
-
-
Karin, M.1
Yamamoto, Y.2
Wang, Q.M.3
-
20
-
-
70349501963
-
Targeting NF-kappaB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer
-
10.1158/1535-7163.MCT-09-0162, 19723887
-
Li B, Li YY, Tsao SW, Cheung AL. Targeting NF-kappaB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer. Mol Cancer Ther 2009, 8:2635-2644. 10.1158/1535-7163.MCT-09-0162, 19723887.
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 2635-2644
-
-
Li, B.1
Li, Y.Y.2
Tsao, S.W.3
Cheung, A.L.4
-
21
-
-
33645693409
-
A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells
-
10.1158/1078-0432.CCR-05-2044, 16551868
-
Shishodia S, Sethi G, Konopleva M, Andreeff M, Aggarwal BB. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells. Clin Cancer Res 2006, 12:1828-1838. 10.1158/1078-0432.CCR-05-2044, 16551868.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1828-1838
-
-
Shishodia, S.1
Sethi, G.2
Konopleva, M.3
Andreeff, M.4
Aggarwal, B.B.5
-
22
-
-
35349001174
-
CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells
-
Deeb D, Gao X, Dulchavsky SA, Gautam SC. CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells. Anticancer Res 2007, 27:3035-3044.
-
(2007)
Anticancer Res
, vol.27
, pp. 3035-3044
-
-
Deeb, D.1
Gao, X.2
Dulchavsky, S.A.3
Gautam, S.C.4
-
23
-
-
0029992609
-
Suppression of TNF-alpha-induced apoptosis by NF-kappaB
-
10.1126/science.274.5288.787, 8864120
-
Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274:787-789. 10.1126/science.274.5288.787, 8864120.
-
(1996)
Science
, vol.274
, pp. 787-789
-
-
Van Antwerp, D.J.1
Martin, S.J.2
Kafri, T.3
Green, D.R.4
Verma, I.M.5
-
24
-
-
0029851617
-
Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required
-
231606, 8887633
-
Van Antwerp DJ, Verma IM. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Mol Cell Biol 1996, 16:6037-6045. 231606, 8887633.
-
(1996)
Mol Cell Biol
, vol.16
, pp. 6037-6045
-
-
Van Antwerp, D.J.1
Verma, I.M.2
-
25
-
-
0037345810
-
The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression
-
10.1016/S1074-7613(03)00053-0, 12648451
-
Wan YY, DeGregori J. The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression. Immunity 2003, 18:331-342. 10.1016/S1074-7613(03)00053-0, 12648451.
-
(2003)
Immunity
, vol.18
, pp. 331-342
-
-
Wan, Y.Y.1
DeGregori, J.2
-
26
-
-
26444605834
-
IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy
-
10.1172/JCI26322, 1236696, 16200195
-
Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy. J Clin Invest 2005, 115:2625-2632. 10.1172/JCI26322, 1236696, 16200195.
-
(2005)
J Clin Invest
, vol.115
, pp. 2625-2632
-
-
Luo, J.L.1
Kamata, H.2
Karin, M.3
-
27
-
-
0034614637
-
The hallmarks of cancer
-
10.1016/S0092-8674(00)81683-9, 10647931
-
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
-
(2000)
Cell
, vol.100
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
28
-
-
19944426112
-
Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas
-
10.1074/jbc.M403492200, 15475567
-
Pacifico F, Mauro C, Barone C, Crescenzi E, Mellone S, Monaco M, Chiappetta G, Terrazzano G, Liguoro D, Vito P. Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas. J Biol Chem 2004, 279:54610-54619. 10.1074/jbc.M403492200, 15475567.
-
(2004)
J Biol Chem
, vol.279
, pp. 54610-54619
-
-
Pacifico, F.1
Mauro, C.2
Barone, C.3
Crescenzi, E.4
Mellone, S.5
Monaco, M.6
Chiappetta, G.7
Terrazzano, G.8
Liguoro, D.9
Vito, P.10
-
29
-
-
27744458480
-
Cell cycle sibling rivalry: Cdc2 vs. Cdk2
-
Kaldis P, Aleem E. Cell cycle sibling rivalry: Cdc2 vs. Cdk2. Cell Cycle 2005, 4:1491-1494.
-
(2005)
Cell Cycle
, vol.4
, pp. 1491-1494
-
-
Kaldis, P.1
Aleem, E.2
-
30
-
-
0343569823
-
P53 regulation of G(2) checkpoint is retinoblastoma protein dependent
-
10.1128/MCB.20.12.4210-4223.2000, 85790, 10825186
-
Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol Cell Biol 2000, 20:4210-4223. 10.1128/MCB.20.12.4210-4223.2000, 85790, 10825186.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 4210-4223
-
-
Flatt, P.M.1
Tang, L.J.2
Scatena, C.D.3
Szak, S.T.4
Pietenpol, J.A.5
-
31
-
-
57549087597
-
Role of NF-kappaB in hematopoietic niche function of osteoblasts after radiation injury
-
10.1016/j.exphem.2008.09.001, 18954936
-
Xiao M, Inal CE, Parekh VI, Li XH, Whitnall MH. Role of NF-kappaB in hematopoietic niche function of osteoblasts after radiation injury. Exp Hematol 2009, 37:52-64. 10.1016/j.exphem.2008.09.001, 18954936.
-
(2009)
Exp Hematol
, vol.37
, pp. 52-64
-
-
Xiao, M.1
Inal, C.E.2
Parekh, V.I.3
Li, X.H.4
Whitnall, M.H.5
-
32
-
-
33746238947
-
Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B
-
10.1038/sj.onc.1209460, 16518410
-
Han SW, Roman J. Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B. Oncogene 2006, 25:4341-4349. 10.1038/sj.onc.1209460, 16518410.
-
(2006)
Oncogene
, vol.25
, pp. 4341-4349
-
-
Han, S.W.1
Roman, J.2
-
33
-
-
33646727546
-
Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest
-
10.1186/1471-2407-6-107, 1464148, 16640785
-
Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 2006, 6:107. 10.1186/1471-2407-6-107, 1464148, 16640785.
-
(2006)
BMC Cancer
, vol.6
, pp. 107
-
-
Raffoul, J.J.1
Wang, Y.2
Kucuk, O.3
Forman, J.D.4
Sarkar, F.H.5
Hillman, G.G.6
-
34
-
-
33751549248
-
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation
-
10.1210/en.2006-0400, 16959844
-
Palona I, Namba H, Mitsutake N, Starenki D, Podtcheko A, Sedliarou I, Ohtsuru A, Saenko V, Nagayama Y, Umezawa K, Yamashita S. BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation. Endocrinology 2006, 147:5699-5707. 10.1210/en.2006-0400, 16959844.
-
(2006)
Endocrinology
, vol.147
, pp. 5699-5707
-
-
Palona, I.1
Namba, H.2
Mitsutake, N.3
Starenki, D.4
Podtcheko, A.5
Sedliarou, I.6
Ohtsuru, A.7
Saenko, V.8
Nagayama, Y.9
Umezawa, K.10
Yamashita, S.11
-
35
-
-
58149456883
-
Death receptors as targets for anti-cancer therapy
-
10.1111/j.1582-4934.2008.00514.x, 19210756
-
Papenfuss K, Cordier SM, Walczakya H. Death receptors as targets for anti-cancer therapy. J Cell Mol Med 2008, 12:2566-2585. 10.1111/j.1582-4934.2008.00514.x, 19210756.
-
(2008)
J Cell Mol Med
, vol.12
, pp. 2566-2585
-
-
Papenfuss, K.1
Cordier, S.M.2
Walczakya, H.3
-
36
-
-
9444245015
-
Linking JNK signaling to NF-kappaB: a key to survival
-
10.1242/jcs.01483, 15483317
-
Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G. Linking JNK signaling to NF-kappaB: a key to survival. J Cell Sci 2004, 117:5197-5208. 10.1242/jcs.01483, 15483317.
-
(2004)
J Cell Sci
, vol.117
, pp. 5197-5208
-
-
Papa, S.1
Zazzeroni, F.2
Pham, C.G.3
Bubici, C.4
Franzoso, G.5
-
37
-
-
0036882166
-
The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis
-
10.1128/MCB.22.24.8571-8579.2002, 139858, 12446776
-
Tang F, Tang G, Xiang G, Dai Q, Rosner MR, Lin A. The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 2002, 22:8571-8579. 10.1128/MCB.22.24.8571-8579.2002, 139858, 12446776.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 8571-8579
-
-
Tang, F.1
Tang, G.2
Xiang, G.3
Dai, Q.4
Rosner, M.R.5
Lin, A.6
-
38
-
-
0037392942
-
The specificities of protein kinase inhibitors: an update
-
10.1042/BJ20021535, 1223271, 12534346
-
Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J 2003, 371:199-204. 10.1042/BJ20021535, 1223271, 12534346.
-
(2003)
Biochem J
, vol.371
, pp. 199-204
-
-
Bain, J.1
McLauchlan, H.2
Elliott, M.3
Cohen, P.4
-
39
-
-
70449441726
-
Tumor necrosis factor-related apoptosis-inducing ligand induces apoptotic cell death through c-Jun NH2-terminal kinase activation in squamous cell carcinoma cells
-
Noutomi T, Itoh M, Toyota H, Takada E, Mizuguchi J. Tumor necrosis factor-related apoptosis-inducing ligand induces apoptotic cell death through c-Jun NH2-terminal kinase activation in squamous cell carcinoma cells. Oncol Rep 2009, 22:1169-1172.
-
(2009)
Oncol Rep
, vol.22
, pp. 1169-1172
-
-
Noutomi, T.1
Itoh, M.2
Toyota, H.3
Takada, E.4
Mizuguchi, J.5
-
40
-
-
0034472617
-
Matrix metalloproteinases in tumor invasion and metastasis
-
10.1006/scbi.2000.0379, 11170864
-
Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000, 10:415-433. 10.1006/scbi.2000.0379, 11170864.
-
(2000)
Semin Cancer Biol
, vol.10
, pp. 415-433
-
-
Stamenkovic, I.1
-
41
-
-
45149092780
-
NF-kappaB and epithelial to mesenchymal transition of cancer
-
10.1002/jcb.21695, 18253935
-
Min C, Eddy SF, Sherr DH, Sonenshein GE. NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 2008, 104:733-744. 10.1002/jcb.21695, 18253935.
-
(2008)
J Cell Biochem
, vol.104
, pp. 733-744
-
-
Min, C.1
Eddy, S.F.2
Sherr, D.H.3
Sonenshein, G.E.4
-
42
-
-
10044262199
-
Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines
-
10.1089/thy.2004.14.881, 15671765
-
Baldini E, Toller M, Graziano FM, Russo FP, Pepe M, Biordi L, Marchioni E, Curcio F, Ulisse S, Ambesi-Impiombato FS, D'Armiento M. Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines. Thyroid 2004, 14:881-888. 10.1089/thy.2004.14.881, 15671765.
-
(2004)
Thyroid
, vol.14
, pp. 881-888
-
-
Baldini, E.1
Toller, M.2
Graziano, F.M.3
Russo, F.P.4
Pepe, M.5
Biordi, L.6
Marchioni, E.7
Curcio, F.8
Ulisse, S.9
Ambesi-Impiombato, F.S.10
D'Armiento, M.11
-
43
-
-
0031298259
-
Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death
-
10.1139/bcb-75-4-337, 9493956
-
Duriez PJ, Shah GM. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol 1997, 75:337-349. 10.1139/bcb-75-4-337, 9493956.
-
(1997)
Biochem Cell Biol
, vol.75
, pp. 337-349
-
-
Duriez, P.J.1
Shah, G.M.2
|